Miriam Gallego-Morales
Madrid, MD 28040, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Cancer-associated fibroblast-derived protein S100-A11 influences the response to anti-HER2 therapies in HER2-positive breast cancer.
Journal: Neoplasia (New York, N.Y.)
Published: March 31, 2026
Next-generation sequencing of TCR clonality discriminates tumor-stage mycosis fungoides from coexisting CD30+ lymphoproliferative disorders.
Journal: Leukemia & lymphoma
Published: October 17, 2025
Molecular Insights into the Diagnosis of Anaplastic Large Cell Lymphoma: Beyond Morphology and Immunophenotype.
Journal: International journal of molecular sciences
Published: May 16, 2025
Adaptive Proteomic Changes in Protein Metabolism and Mitochondrial Alterations Associated with Resistance to Trastuzumab and Pertuzumab Therapy in HER2-Positive Breast Cancer.
Journal: International journal of molecular sciences
Published: December 16, 2024
Generation and Characterization of Trastuzumab/Pertuzumab-Resistant HER2-Positive Breast Cancer Cell Lines.
Journal: International journal of molecular sciences
Published: November 13, 2023
Redox signalling regulates breast cancer metastasis via phenotypic and metabolic reprogramming due to p63 activation by HIF1α.
Journal: British journal of cancer
Published: March 16, 2023
Tumor-Infiltrating Lymphocytes and Immune Response in HER2-Positive Breast Cancer.
Journal: Cancers
Published: October 17, 2022
MicroRNA-199b Deregulation Shows Oncogenic Properties and Promising Clinical Value as Circulating Marker in Locally Advanced Rectal Cancer Patients.
Journal: International journal of molecular sciences
Published: December 29, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026